Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis ; volume:21 ; number:1 ; day:24 ; month:5 ; year:2021 ; pages:1-8 ; date:12.2021
BMC cancer ; 21, Heft 1 (24.5.2021), 1-8, 12.2021
- Urheber
-
Rustgi, Sheila D.
Oh, Aaron
Yang, Jeong Yun
Kang, Dasol
Wolin, Edward
Kong, Chung Y.
Hur, Chin
Kim, Michelle K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-021-08306-5
- URN
-
urn:nbn:de:101:1-2021092020413852428052
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rustgi, Sheila D.
- Oh, Aaron
- Yang, Jeong Yun
- Kang, Dasol
- Wolin, Edward
- Kong, Chung Y.
- Hur, Chin
- Kim, Michelle K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
Somatostatin analogues labeled with copper radioisotopes: current status
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program
Peptides in oncology, 2.. Somatostatin analogues and Bombesin antagonists : with 14 tables
Peptides in oncology, 3.. Somatostatin and LH-RH analogues : with 14 tables
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Somatostatin receptor PET/CT in the management of patients with neuroendocrine tumors
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
Somatostatin analogues labeled with copper radioisotopes: current status
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program
Peptides in oncology, 2.. Somatostatin analogues and Bombesin antagonists : with 14 tables
Peptides in oncology, 3.. Somatostatin and LH-RH analogues : with 14 tables
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Somatostatin receptor PET/CT in the management of patients with neuroendocrine tumors
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
Somatostatin analogues labeled with copper radioisotopes: current status
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program
Peptides in oncology, 2.. Somatostatin analogues and Bombesin antagonists : with 14 tables
Peptides in oncology, 3.. Somatostatin and LH-RH analogues : with 14 tables
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Somatostatin receptor PET/CT in the management of patients with neuroendocrine tumors
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors